Related Experiment Videos
An automated method for discriminating aneugen- vs. clastogen-induced micronuclei
D K Torous1, S D Dertinger, N E Hall
1Litron Laboratories, Rochester, New York 14620, USA.
Environmental and Molecular Mutagenesis
|July 8, 1998
Summary
This study shows flow cytometry can quantify micronuclei (MN) in mouse blood. It effectively distinguishes MN caused by aneugens from those caused by clastogens using DNA content analysis.
Area of Science:
- Toxicology
- Genetics
- Biotechnology
Background:
- Micronuclei (MN) are indicators of genotoxicity.
- Distinguishing aneugen- and clastogen-induced MN is crucial for toxicological assessments.
- Flow cytometry offers a high-throughput method for cellular analysis.
Purpose of the Study:
- To evaluate a flow cytometric (FCM) procedure for quantifying micronucleated reticulocytes.
- To determine if FCM can discriminate between aneugen- and clastogen-induced micronuclei (MN).
- To assess the utility of DNA content analysis for differentiating MN types.
Main Methods:
- BALB/c mice were treated with saline, methyl methanesulfonate (clastogen), or vincristine (aneugen).
- Peripheral blood samples were analyzed using FCM with anti-CD71 and propidium iodide staining.
- Micronucleated reticulocytes were quantified, and MN DNA content was analyzed via histogram analysis.
Main Results:
- Flow cytometry successfully quantified micronucleated reticulocytes.
- A significant difference in DNA content was observed between MN induced by aneugens and those from clastogens or spontaneous events.
- The "median channel" histogram statistic effectively quantified MN distribution based on DNA content.
Conclusions:
- Flow cytometry is a viable method for measuring MN incidence from both clastogenic and aneugenic exposures.
- FCM analysis of MN DNA content allows for discrimination between aneugen-induced MN and those from clastogens or spontaneous events.
- This FCM approach provides a quantitative tool for genotoxicity testing.